Molecular signaling and clinical implications in the human aging-cancer cycle
Seminars in Cancer Biology · 2024-11 · 106-107 · 28-42
DOI: 10.1016/j.semcancer.2024.08.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024-11. Verfasst von Abdol-Hossein Rezaeian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States. Electronic address: arezaeia@…. Hauptthemen laut MEDLINE: Neoplasms, Aging, Signal Transduction, Cellular Senescence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States. Electronic address: arezaeia@bidmc.harvard.edu.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States. Electronic address: wwei2@bidmc.harvard.edu.
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Rezaeian, A. H., & Wei, W. (2024). Molecular signaling and clinical implications in the human aging-cancer cycle. Seminars in Cancer Biology, 106-107, 28-42. https://doi.org/10.1016/j.semcancer.2024.08.003
Vancouver
Rezaeian AH, Wei W. Molecular signaling and clinical implications in the human aging-cancer cycle. Seminars in Cancer Biology. 2024;106-107:28-42. doi:10.1016/j.semcancer.2024.08.003
BibTeX
@article{Rezaeian2024,
author = {Rezaeian, Abdol-Hossein and Wei, Wenyi},
title = {Molecular signaling and clinical implications in the human aging-cancer cycle},
journal = {Seminars in Cancer Biology},
year = {2024},
volume = {106-107},
pages = {28--42},
doi = {10.1016/j.semcancer.2024.08.003}
}
EUVIMED